Key countries
Discovery and Development Teams
Value & Access
Medical Affairs
Marketing
Global Product Strategy
Value & Access is responsible for demonstrating the value of our products – which is more important than ever, given increasing budgetary constraints in healthcare systems across the world. As an engaged member of the healthcare ecosystem, Idorsia understands its responsibility to help find solutions to the high cost of healthcare, and we are committed to playing our part in supporting patient access to our medicines. The prices of our medicines will reflect the value that our innovations deliver, generating revenues to fuel the discovery and development of future molecules. To demonstrate meaningful innovation, we develop a value proposition, underpinned by our science and clinical data, to help payors determine the value offered by our treatments compared to existing options. Our ultimate goal is to help patients gain access to our treatments through reimbursement or other coverage arrangements.
Value & Access
Marketing
Global Marketing generates deep insights from patients and healthcare professionals, which help us to gain a holistic understanding of our customers’ needs. This helps us to address unmet needs in the marketplace and to clearly differentiate our brands. We also focus our marketing efforts on raising awareness among patients, healthcare professionals, and other key stakeholders (e.g. policymakers) of the impact of the conditions targeted by our products.
Idorsia’s Global Medical Affairs team is responsible for communicating to the healthcare community our science, the data on our products, and the key differences from other treatments. To inform and develop our global strategy, we also seek medical insights regarding how our products’ core data resonates with physicians. Our medical and clinical development teams continue to generate new evidence for approved products – with real world evidence in high demand among payors and physicians alike. Importantly, this team also manages Idorsia’s repository of medical information and has developed an intelligent digital platform, providing 24/7 self-service access to scientifically robust, balanced, and easily digestible information.
Medical Affairs
While our product strategies are global, our country teams own the execution of their local launches and customer relationships, and they tailor the global strategies to their markets. Working closely together, our affiliates and global teams all play a role in ensuring a successful launch and thus maximizing the value of Idorsia’s innovation.
Key
countries
Discovery and Development Teams
The commercial organization teams up with people from across Idorsia to gather insights from the discovery and development phases and ensure that science is at the core of our global product strategies. For example, our development team members share learnings about the needs of patients and healthcare professionals from our clinical trials, and also partner with our medical affairs group to shape how we continue to gather data about our treatments.
Once approved by the local health authorities, a drug enters the market and physicians may prescribe it to patients. Patient access to a drug is often determined by the drug reimbursement system and payor decisions about the treatment.
Value & Access
Value & Access is responsible for demonstrating the value of our products – which is more important than ever, given increasing budgetary constraints in healthcare systems across the world. As an engaged member of the healthcare ecosystem, Idorsia understands its role to help find solutions to the high cost of healthcare and is committed to doing our part in supporting patient access to our medicines. The prices of our medicines will reflect the value that our innovations deliver, which generates revenues to fuel the discovery and development of future molecules. To demonstrate meaningful innovation, we develop a value proposition, underpinned by our science and clinical data, to help payors determine the value offered by our treatments compared to existing options. Our ultimate goal is to help patients gain access to our treatments through reimbursement or other coverage arrangements.
Marketing
Global Marketing generates deep insights from patients and healthcare professionals, which help us to gain a holistic understanding of our customers’ needs. This helps us to address unmet needs in the marketplace and to clearly differentiate our brands. We also focus our marketing efforts on raising awareness among patients, healthcare professionals and other key stakeholders (e.g. policymakers) of the impact of the conditions targeted by our products.
Medical Affairs
Idorsia’s Global Medical Affairs team is responsible for communicating to the healthcare community our science, the data on our products, and the key differences from other treatments. To inform and develop our global strategy, we also seek medical insights regarding how our products’ core data resonates with physicians. Our medical and clinical development teams continue to generate new evidence for approved products – with real-world evidence in high demand among payors and physicians alike. Importantly, this team also manages Idorsia’s repository of medical information and has developed an intelligent digital platform, providing 24/7 self-service access to scientifically robust, balanced, and easily digestible information.
Key countries
While our product strategies are global, our country teams own the execution of their local launches and customer relationships, and they tailor the global strategies to their markets. Working closely together, our affiliates and global teams all play a role in ensuring a successful launch and thus maximizing the value of Idorsia’s innovation.
Discovery and Development Teams